Log in

NASDAQ:SILK - Silk Road Medical Stock Price, Forecast & News

$35.18
+0.25 (+0.72 %)
(As of 12/9/2019 01:11 AM ET)
Today's Range
$34.79
Now: $35.18
$35.79
50-Day Range
$32.00
MA: $35.23
$37.68
52-Week Range
$27.83
Now: $35.18
$51.50
Volume371,646 shs
Average Volume277,902 shs
Market Capitalization$1.09 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Silk Road Medical, Inc. operates as a medical device company in the United States. It offers ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent with clinical data regarding lasting safety outcomes; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was founded in 2007 and is headquartered in Sunnyvale, California.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SILK
CUSIPN/A
CIKN/A
Phone408-720-9002

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$34.56 million

Profitability

Net Income$-37,630,000.00
Net Margins-106.32%

Miscellaneous

Employees176
Market Cap$1.09 billion
Next Earnings Date2/4/2020 (Estimated)
OptionableNot Optionable

Receive SILK News and Ratings via Email

Sign-up to receive the latest news and ratings for SILK and its competitors with MarketBeat's FREE daily newsletter.


Silk Road Medical (NASDAQ:SILK) Frequently Asked Questions

What is Silk Road Medical's stock symbol?

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

How were Silk Road Medical's earnings last quarter?

Silk Road Medical Inc (NASDAQ:SILK) posted its earnings results on Tuesday, October, 29th. The company reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.01. The company earned $17 million during the quarter, compared to analysts' expectations of $15.93 million. The company's revenue was up 77.1% compared to the same quarter last year. View Silk Road Medical's Earnings History.

When is Silk Road Medical's next earnings date?

Silk Road Medical is scheduled to release their next quarterly earnings announcement on Tuesday, February 4th 2020. View Earnings Estimates for Silk Road Medical.

What price target have analysts set for SILK?

5 equities research analysts have issued 1 year price targets for Silk Road Medical's stock. Their forecasts range from $40.01 to $52.00. On average, they anticipate Silk Road Medical's stock price to reach $44.80 in the next twelve months. This suggests a possible upside of 27.4% from the stock's current price. View Analyst Price Targets for Silk Road Medical.

What is the consensus analysts' recommendation for Silk Road Medical?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Silk Road Medical.

Has Silk Road Medical been receiving favorable news coverage?

Press coverage about SILK stock has been trending very negative recently, InfoTrie reports. The research firm rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Silk Road Medical earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for Silk Road Medical.

Are investors shorting Silk Road Medical?

Silk Road Medical saw a decrease in short interest in the month of November. As of November 15th, there was short interest totalling 1,790,000 shares, a decrease of 30.4% from the October 31st total of 2,570,000 shares. Based on an average daily trading volume, of 295,200 shares, the short-interest ratio is presently 6.1 days. Approximately 9.3% of the company's shares are sold short. View Silk Road Medical's Current Options Chain.

Who are some of Silk Road Medical's key competitors?

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Alibaba Group (BABA), Splunk (SPLK), Home Depot (HD), Thermo Fisher Scientific (TMO), Cisco Systems (CSCO), DexCom (DXCM), Workday (WDAY), salesforce.com (CRM), Veeva Systems (VEEV) and Netflix (NFLX).

Who are Silk Road Medical's key executives?

Silk Road Medical's management team includes the folowing people:
  • Ms. Erica J. Rogers, Chief Exec. Officer, Pres & Director (Age 55)
  • Mr. Lucas W. Buchanan, Chief Financial Officer (Age 41)
  • Mr. Robert A. Nicholas, VP of Operations & Engineering (Age 56)
  • Mr. Andrew S. Davis, Exec. VP of Global Sales & Marketing (Age 50)
  • Ms. Alison Highlander, VP of HR

When did Silk Road Medical IPO?

(SILK) raised $75 million in an initial public offering (IPO) on Thursday, April 4th 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

Who are Silk Road Medical's major shareholders?

Silk Road Medical's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include TimesSquare Capital Management LLC (1.95%), Great Point Partners LLC (0.98%), Massachusetts Financial Services Co. MA (0.90%), State Street Corp (0.61%), Rhenman & Partners Asset Management AB (0.41%) and SG Americas Securities LLC (0.08%). Company insiders that own Silk Road Medical stock include Andrew S Davis, Erica J Rogers, Lucas W Buchanan, Pincus & Co Warburg, Richard Ruedy and X Finance LP Wp. View Institutional Ownership Trends for Silk Road Medical.

Which institutional investors are selling Silk Road Medical stock?

SILK stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA. Company insiders that have sold Silk Road Medical company stock in the last year include Andrew S Davis, Erica J Rogers, Lucas W Buchanan, Pincus & Co Warburg, Richard Ruedy and X Finance LP Wp. View Insider Buying and Selling for Silk Road Medical.

Which institutional investors are buying Silk Road Medical stock?

SILK stock was acquired by a variety of institutional investors in the last quarter, including Great Point Partners LLC, TimesSquare Capital Management LLC, Rhenman & Partners Asset Management AB, State Street Corp, SG Americas Securities LLC, California State Teachers Retirement System, Squarepoint Ops LLC and Coastal Investment Advisors Inc.. View Insider Buying and Selling for Silk Road Medical.

How do I buy shares of Silk Road Medical?

Shares of SILK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Silk Road Medical's stock price today?

One share of SILK stock can currently be purchased for approximately $35.18.

How big of a company is Silk Road Medical?

Silk Road Medical has a market capitalization of $1.09 billion and generates $34.56 million in revenue each year. Silk Road Medical employs 176 workers across the globe.View Additional Information About Silk Road Medical.

What is Silk Road Medical's official website?

The official website for Silk Road Medical is http://silkroadmed.com/.

How can I contact Silk Road Medical?

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The company can be reached via phone at 408-720-9002 or via email at [email protected]


MarketBeat Community Rating for Silk Road Medical (NASDAQ SILK)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  30 (Vote Outperform)
Underperform Votes:  26 (Vote Underperform)
Total Votes:  56
MarketBeat's community ratings are surveys of what our community members think about Silk Road Medical and other stocks. Vote "Outperform" if you believe SILK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SILK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/9/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel